94317 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups - condensed with carbocyclic rings or ring systems; Ortho- or peri-condensed ring systems Ring systems of three rings
Sub-classes:Organic Electroluminescent Device
#2NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
#3DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES COMPOUNDS
#4TETRAHYDROBENZO-QUINOLINE SULFONAMIDE DERIVATIVES USEFUL AS IGE MODULATORS
#5Heterocyclic compounds
#6Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
#7NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION
#8INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1
#9Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#10Compound and dimer complex embodiments for supramolecular sensing
#11Azulene ring-containing compound, its use, and an organic photoelectric device including the same
#12Tricyclic compounds as histone methyltransferase inhibitors
#13BENZO-HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS
#14Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application
#15Inhibitors of kidney-type glutaminase, GLS-1
#16Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
#17BENZOQUINOLONE INHIBITORS OF VMAT2
#18Organic electroluminescence device
#19Heterocyclic compound and organic light emitting device using same
#20Selective inhibitors of gentotoxic steress-induced IKK/NF-κB pathways
#21Heterocyclic compound, and organic light-emitting device using same
#22Cannabinergic nitrate esters and related analogs
#23Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease
#24Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application
#25Compositions of protein receptor tyrosine kinase inhibitors
#26Inhibitors of kidney-type glutaminase, GLS-1
#27Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#28Spiroacridine-triazine hybrids and applications for electroluminescent devices
#29BENZOQUINOLONE INHIBITORS OF VMAT2
#30Cannabinergic nitrate esters and related analogs
#31Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#32Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
#33Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
#34BENZOQUINOLINE INHIBITORS OF VMAT 2
#35Cannabinergic nitrate esters and related analogs
#36NOVEL ANTIVIRAL COMPOUNDS
#37Organic electroluminescence device
#38Compositions of protein receptor tyrosine kinase inhibitors
#39Tricyclic compounds and PBK inhibitors containing the same
#40HEXAHYDROINDENOPYRIDINE DERIVATIVES
#41COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES
#42REDUCING TRANSMISSION OF SEXUALLY TRANSMITTED INFECTIONS
#43Compounds and methods for purification of serine proteases
#44Indenopyridine derivatives
#45Quinolone compound and pharmaceutical composition
#46Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
#47Antiviral compounds
#48Compounds for modulating RNA binding proteins and uses therefor
#49Tricyclic compounds and PBK inhibitors containing the same
#50Fused ring pyridine compound
#514-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
#52Organic electroluminescence device
#53Quinolone compound and pharmaceutical composition
#54Small molecule inhibitors of the α4-paxillin interaction
#55Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
#56Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
#57Organic electroluminescence device
#58Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor
#59Fused piperidine compound and pharmaceutical containing same
#60BENZOQUINOLONE INHIBITORS OF VMAT2
#61Compositions of protein receptor tyrosine kinase inhibitors
#62Quinolone compound and pharmaceutical composition
#63Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
#646-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2
#65Selectively Functionalized Rylene Imides and Diimides
#66Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
#67Compounds for modulating RNA binding proteins and uses therefor
#68SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS
#69COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
#70Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds
#71Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
#72Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
#73CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF
#74Catecholamine derivatives and prodrugs thereof
#75Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
#766-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine Dreceptor
#77Catalysts for olefin polymerization or oligomerization
#78PROCESS FOR THE PREPARATION OF DESLORATADINE POLYMORPH MIXTURES
#79Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method
#80BRIDGED PHENANTHRIDINES
#81Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5
#82Monomer having sulfonyl group, polymer thereof and photoresist composition including the same
#83Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
#84Process for the synthesis of compounds for selectin inhibition
#85Substituted piperidine compounds and methods of their use
#86Quinoline derivative, its use, production and pharmaceutical agents containing the latter
#87Catalysts for olefin polymerization or oligomerization
#88Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
#89Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#90Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#91Compositions and methods for modulating interaction between polypeptides
#92Substituted piperidine compounds and methods of their use
#93Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#94Aqueous Na-ion redox flow battery with ceramic NaSICON membrane